Home

What We Do

E-Fund was founded with the goal to achieve consistently higher returns and more exits from angel investments. By investing via teams, we are able to do more due diligence, leverage the industry expertise of our investors and provide post investment advice to the companies we invested in.

Investing with E-Fund

Join our team of angel investors and enjoy the rewards of angel investing.

Angel Investing

Diversify your portfolio and invest in local entrepreneurs.

I’m Looking For Funding

Looking for the right angel investor? Here is what we’re looking for.

Want to Learn More About Angel Investing with E-Fund?

Read our latest newsletter for a quick overview of events and investor updates
Meet with an E-Fund Investment Team Member and get complimentary copy of “A Practical Guide to Angel Investing“
Join an E-Fund Event or Workshop or monthly VANTEC Angel Network meetings
Sign up below for our E-Fund Angel Investing Newsletter and get notified for upcoming workshops and events.

Upcoming Events

These events are graciously supported by NACO Western Canadian Angel Network Program and Western Economic Diversification Canada

Our Investment Activity Since 2011

1,020
Deals Screened

102
Follow Up Meetings

53
Due Diligence Reports

21
Investments

4
Exits to Date

Our Portfolio Companies

Target Tape

TargetTape is clinically testing functional prototypes based upon their new patent-pending product embodiment in US and Canadian surgeries and is commercializing the device.

2016-09-10T07:44:37+00:00

TargetTape is clinically testing functional prototypes based upon their new patent-pending product embodiment in US and Canadian surgeries and is commercializing the device.

http://www.e-fund.ca/blog/testimonials/target-tape/

Semios

Semios develops a range of proprietary chemical compositions to precision pheromone release and monitoring systems.

2016-09-10T07:52:00+00:00

Semios develops a range of proprietary chemical compositions to precision pheromone release and monitoring systems.

http://www.e-fund.ca/blog/testimonials/semios/

ImStar Therapeutics

ImStar Therapeutics is working on a new approach to treat patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease.

2016-09-12T01:59:34+00:00

ImStar Therapeutics is working on a new approach to treat patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease.

http://www.e-fund.ca/blog/testimonials/imstar-therapeutics/

Redlen Technologies

Redlen Technologies manufactures Cadmium Zinc Telluride based semiconductor materials that have unique radiation detection properties.

2016-09-12T02:04:23+00:00

Redlen Technologies manufactures Cadmium Zinc Telluride based semiconductor materials that have unique radiation detection properties.

http://www.e-fund.ca/blog/testimonials/redlen-technologies/

Optigo Networks

Optigo Networks specializes in innovative connectivity solutions for smart buildings and security around those systems.

2016-09-12T02:06:21+00:00

Optigo Networks specializes in innovative connectivity solutions for smart buildings and security around those systems.

http://www.e-fund.ca/blog/testimonials/optigo-networks/

Mazza Innovation

Mazza Innovation has commercialized the world’s first phytochemical extraction technology, producing high value extracts from plants, using sustainable, high performance and cost effective science.

2016-09-12T02:29:16+00:00

Mazza Innovation has commercialized the world’s first phytochemical extraction technology, producing high value extracts from plants, using sustainable, high performance and cost effective science.

http://www.e-fund.ca/blog/testimonials/mazza-innovation/

BitLit Media

BitLit Media has launched an app that lets you download an eBook of a print book you own. It is called “Shelfie” (@shelfie) which allows people to get e-book versions of physical books in their library via the patented technology and alliances with most major North American publishers.

2016-09-12T02:31:07+00:00

BitLit Media has launched an app that lets you download an eBook of a print book you own. It is called “Shelfie” (@shelfie) which allows people to get e-book versions of physical books in their library via the patented technology and alliances with most major North American publishers.

http://www.e-fund.ca/blog/testimonials/bitlit-media/

ViewsIQ

Views IQ is a medical imaging company focusing on biological microscopic applications of pathology slides. This challenging arena is the last frontier in medical digitizing technologies.

2016-09-12T02:38:37+00:00

Views IQ is a medical imaging company focusing on biological microscopic applications of pathology slides. This challenging arena is the last frontier in medical digitizing technologies.

http://www.e-fund.ca/blog/testimonials/viewsiq/

Wearable Therapeutics

Wearable Therapeutics is best known in North America by the name of its signature product, “SnugVest” (@Snugvest). SnugVest calms people suffering from autism and other problems by simulating a hug.

2016-09-12T04:47:31+00:00

Wearable Therapeutics is best known in North America by the name of its signature product, “SnugVest” (@Snugvest). SnugVest calms people suffering from autism and other problems by simulating a hug.

http://www.e-fund.ca/blog/testimonials/wearable-therapeutics/

Aspect Biosystems

Aspect Biosystems is a biotechnology company specializing in 3D bioprinting and tissue engineering.

2016-09-12T04:50:17+00:00

Aspect Biosystems is a biotechnology company specializing in 3D bioprinting and tissue engineering.

http://www.e-fund.ca/blog/testimonials/aspect-biosystems/

Microdermics

Microdermics is a Vancouver-based company focused on commercializing a novel hollow microneedle delivery platform targeting the multi-billion biopharmaceutical market, disrupting the traditional use of hypodermic-based drug injections. E-Fund invested in February 2017. E-Fund II and III

2017-03-13T10:20:08+00:00

Microdermics is a Vancouver-based company focused on commercializing a novel hollow microneedle delivery platform targeting the multi-billion biopharmaceutical market, disrupting the traditional use of hypodermic-based drug injections. E-Fund invested in February 2017. E-Fund II and III

http://www.e-fund.ca/blog/testimonials/microdermics/

Proxxi

Proxxi has developed an industrial wearable that keeps watch over people working near medium and high voltage. It is designed to prevent injury or death by alerting the wearer before they enter the 'limits of approach' of a high voltage electrical field. E-Fund invested in March 2017. E-Fund II and III

2017-03-13T10:24:39+00:00

Proxxi has developed an industrial wearable that keeps watch over people working near medium and high voltage. It is designed to prevent injury or death by alerting the wearer before they enter the 'limits of approach' of a high voltage electrical field. E-Fund invested in March 2017. E-Fund II and III

http://www.e-fund.ca/blog/testimonials/2747/